Trading Pipette for Pen, Assay for Essay

In 1993, Jamie Zhang was in a career funk not uncommon among biologists with Ph.D.s. Three years out of graduate school, she was in her second postdoctoral job, studying the molecular biology of cancer at Rutgers University. But she wasn't satisfied in the lab--and hadn't been for a long time. "Everybody's unhappy as a graduate student," she observes. "Then in my first postdoc, I just felt like I was spinning my wheels." She blamed the feeling on her doubts about her project and on the differen

Written byDouglas Steinberg
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

In 1993, Jamie Zhang was in a career funk not uncommon among biologists with Ph.D.s. Three years out of graduate school, she was in her second postdoctoral job, studying the molecular biology of cancer at Rutgers University. But she wasn't satisfied in the lab--and hadn't been for a long time. "Everybody's unhappy as a graduate student," she observes. "Then in my first postdoc, I just felt like I was spinning my wheels." She blamed the feeling on her doubts about her project and on the different approaches of her and her boss.

It was only in her second postdoc, Zhang recalls, that "it finally dawned on me that I just, plain and simple, didn't like research. Then I started to think, what do I like? And it was writing. I was one of those oddballs that actually didn't mind writing her thesis." After answering several ads for medical writers, Zhang ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies